Home > Insider Trading > Eikon Therapeutics Inc. > Profile

Eikon Therapeutics Inc. (EIKN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

Sector: Healthcare

Insider Roster

Column Group Opportunity Iii Gp, Lp, 2026-09-08
Tcg Opportunity Iii Gp, Llc, 2026-09-08
Column Group Opportunity Iii, Lp, 2026-09-08

Column Group Opportunity Iii Gp, Lp, 2026-09-08
Tcg Opportunity Iii Gp, Llc, 2026-09-08
Column Group Opportunity Iii, Lp, 2026-09-08
Column Group Iv Gp, Lp, 2026-09-08
Column Group Iv, Lp, 2026-09-08
Column Group Iv-A, Lp, 2026-09-08
Tim Kutzkey, 2026-09-08
Peter Svennilson, 2026-09-08
Fatima Ma. Francisco, 2026-06-15
A Michael Klobuchar, Chief Operating Officer, 2026-03-04
Luther Robert Huffines, 2026-03-04
C Kenneth Frazier, 2026-03-04
M Roger Perlmutter, See Remarks, 2026-03-04
Bruno Benjamin Thorner, See Remarks, 2026-03-04
D. Roy Baynes, Chief Medical Officer, 2026-03-04
Jr. Lloyd Alfred Bowie, Chief Financial Officer, 2026-03-04
Foresite Capital Vi-A Management, Llc, Large Shareholder, 2026-02-07
Foresite Capital Vi-A, Llc, Large Shareholder, 2026-02-07
Foresite Capital Opportunity Management V, Llc, Large Shareholder, 2026-02-07
Foresite Capital Management V, Llc, Large Shareholder, 2026-02-07
Foresite Capital Opportunity Fund V, L.p., Large Shareholder, 2026-02-07
Foresite Capital Fund V, L.p., Large Shareholder, 2026-02-07
Foresite Capital Management Iv, Llc, Large Shareholder, 2026-02-07
Foresite Capital Fund Iv, L.p., Large Shareholder, 2026-02-07
Josh Wolfe, 2026-02-06
Lux Total Opportunities, L.p., 2026-02-06
Lux Co-Invest Opportunities Ii, L.p., 2026-02-06
Lux Venture Partners V, Llc, 2026-02-06
Lux Ventures V, L.p., 2026-02-06
Peter Hebert, 2026-02-06
W David Meline, 2026-02-05
Leon Chen, 2026-02-05

Show All Insiders (32)

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Column	$11.56	89,200	$1,031,044.96	89,200	2026-09-03	Filing
Column	$18.00	630,881	$11,355,858.00	1,319,164	2026-02-06	Filing
Column	$18.00	49,556	$892,008.00	148,840	2026-02-06	Filing
Column	$18.00	1,437,323	$25,871,814.00	4,312,139	2026-02-06	Filing
Foresite Large Shareholder	$18.00	55,555	$999,990.00	1,318,983	2026-02-04	Filing

News See All

Is Eikon Therapeutics, Inc. (EIKN) Stock a Biotech Growth Opportunity Despite Limited Q1 Updates?

We recently compiled a list of the 8 Best Up and Coming Pharmaceutical Stocks to Buy Now. Eikon Therapeutics, Inc. (NASDAQ:EIKN) is one of the best up and coming stocks on our list.

Keep Reading →

July 2nd, 2026 - News